Journal of Rheumatic Diseases

Cited by CrossRef (9)

  1. Byung-Wook Song, A-Ran Kim, Yun-Kyung Kim, Geun-Tae Kim, Eun-Young Ahn, Min-Wook So, Seung-Geun Lee. Diagnostic Value of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Monocyte-to-Lymphocyte Ratios for the Assessment of Rheumatoid Arthritis in Patients with Undifferentiated Inflammatory Arthritis. Diagnostics 2022;12:1702
    https://doi.org/10.3390/diagnostics12071702
  2. Se Rim Choi, Soo-Kyung Cho, Yoon-Kyoung Sung. Application of disease activity index in rheumatoid arthritis management in Korea. J Rheum Dis 2024;31:193
    https://doi.org/10.4078/jrd.2024.0077
  3. Yeo-Jin Song, Soo-Kyung Cho, Yu-Seon Jung, Sun-Young Jung, Jihyun Keum, Eunwoo Nam, Yoon-Kyoung Sung, Dae Hyun Yoo. Medication utilisation trends during pregnancy and factors influencing adverse pregnancy outcomes in patients with rheumatoid arthritis. RMD Open 2024;10:e003739
    https://doi.org/10.1136/rmdopen-2023-003739
  4. Rehab Abd El-AL Elnemr, Nehad Mohamed Elshatby. Could hematological indices predict the response of rheumatoid arthritis patients to biological drugs?. Egypt Rheumatol Rehabil 2024;51
    https://doi.org/10.1186/s43166-024-00296-z
  5. Seulkee Lee, Seonyoung Kang, Yeonghee Eun, Hong-Hee Won, Hyungjin Kim, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha. Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Res Ther 2021;23
    https://doi.org/10.1186/s13075-021-02635-3
  6. Sang Youn Jung, Jung Hee Koh, Ki-Jo Kim, Yong-Wook Park, Hyung-In Yang, Sung Jae Choi, Jisoo Lee, Chan-Bum Choi, Wan-Uk Kim. Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial. Arthritis Res Ther 2021;23
    https://doi.org/10.1186/s13075-021-02566-z
  7. Min Wook So, A-Ran Kim, Seung-Geun Lee. Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis. Rheumatol Ther 2024;11:881
    https://doi.org/10.1007/s40744-024-00674-1
  8. Fatemeh Salehi, Luis I. Lopera Gonzalez, Sara Bayat, Arnd Kleyer, Dario Zanca, Alexander Brost, Georg Schett, Bjoern M. Eskofier. Machine Learning Prediction of Treatment Response to Biological Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. JCM 2024;13:3890
    https://doi.org/10.3390/jcm13133890
  9. Hyun Jin Park, Boyoon Choi, Yun-Kyoung Song, Yoon-Jeong Oh, Eun Bong Lee, In-Wha Kim, Jung Mi Oh. Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study. JCM 2023;12:6998
    https://doi.org/10.3390/jcm12226998